Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

172 8 Interleukin-10 in Cancer Immunity
pression by IL-10. J Immunol 1994; 152:
3559±69.
76 Niiro H, Otsuka T, Izuhara K, et al.
Regulation by interleukin-10 and interleukin-4
of cyclooxygenase-2 expression
in human neutrophils. Blood 1997; 89:
1621±8.
77 Takanaski S, Nonaka R, Xing Z,
O'Byrne P, Dolovich J, Jordana M.
Interleukin 10 inhibits lipopolysaccharide-induced
survival and cytokine production
by human peripheral blood eosinophils.
J Exp Med 1994; 180: 711±5.
78 Arock M, Zuany-Amorim C, Singer M,
Benhamou M, Pretolani M. Interleukin-10
inhibits cytokine generation from
mast cells. Eur J Immunol 1996; 26: 166±
70.
79 Lin TJ, Befus AD. Differential regulation
of mast cell function by IL-10 and
stem cell factor. J Immunol 1997; 159:
4015±23.
80 Rissoan MC, Soumelis V, Kadowaki
N, et al. Reciprocal control of T helper
cell and dendritic cell differentiation.
Science 1999; 283: 1183±6.
81 Kruger-Krasagakes S, Krasagakis K,
Garbe C, et al. Expression of interleukin
10 in human melanoma. Br J Cancer
1994; 70: 1182±5.
82 Dummer W, Bastian BC, Ernst N,
Schanzle C, Schwaaf A, Brocker EB.
Interleukin-10 production in malignant
melanoma: preferential detection of IL-
10-secreting tumor cells in metastatic
lesions. Int J Cancer 1996; 66: 607±10.
83 Smith DR, Kunkel SL, Burdick MD,
et al. Production of interleukin-10 by
human bronchogenic carcinoma. Am J
Pathol 1994; 145: 18±25.
84 Kim J, Modlin RL, Moy RL, et al. IL-10
production in cutaneous basal and
squamous cell carcinomas. A mechanism
for evading the local T cell immune
response. J Immunol 1995; 155: 2240±7.
85 Kitabayashi A, Hirokawa M, Miura
AB. The role of interleukin-10 (IL-10) in
chronic B-lymphocytic leukemia: IL-10
prevents leukemic cells from apoptotic
cell death. Int J Hematol 1995; 62: 99±
106.
86 Masood R, Zhang Y, Bond MW, et al.
Interleukin-10 is an autocrine growth
factor for acquired immunodeficiency
syndrome-related B-cell lymphoma.
Blood 1995; 85: 3423±30.
87 Sjoberg J, Aguilar-Santelises M,
Sjogren AM, et al. Interleukin-10
mRNA expression in B-cell chronic
lymphocytic leukaemia inversely correlates
with progression of disease. Br J
Haematol 1996; 92: 393±400.
88 Beatty PR, Krams SM, Martinez OM.
Involvement of IL-10 in the autonomous
growth of EBV-transformed B cell
lines. J Immunol 1997; 158: 4045±51.
89 Boulland ML, Meignin V, Leroy-
Viard K, et al. Human interleukin-10
expression in T/natural killer-cell lymphomas:
association with anaplastic
large cell lymphomas and nasal natural
killer-cell lymphomas. Am J Pathol
1998; 153: 1229±37.
90 Jones KD, Aoki Y, Chang Y, Moore
PS,Yarchoan R, Tosato G. Involvement
of interleukin-10 (IL-10) and viral
IL-6 in the spontaneous growth of Kaposi's
sarcoma herpesvirus-associated
infected primary effusion lymphoma
cells. Blood 1999; 94: 2871±9.
91 Pisa P, Halapi E, Pisa EK, et al. Selective
expression of interleukin 10, interferon
g, and granulocyte-macrophage
colony-stimulating factor in ovarian
cancer biopsies. Proc Natl Acad Sci USA
1992; 89: 7708±12.
92 Nakagomi H, Pisa P, Pisa EK, et al.
Lack of interleukin-2 (IL-2) expression
and selective expression of IL-10 mRNA
in human renal cell carcinoma. Int J
Cancer 1995; 63: 366±71.
93 Menetrier-Caux C, Bain C, Favrot
MC, Duc A, Blay JY. Renal cell carcinoma
induces interleukin 10 and prostaglandin
E2 production by monocytes.
Br J Cancer 1999; 79: 119±30.
94 Loercher AE, Nash MA, Kavanagh
JJ, Platsoucas CD, Freedman RS.
Identification of an IL-10±producing
HLA-DR-negative monocyte subset in
the malignant ascites of patients with
ovarian carcinoma that inhibits cytokine
protein expression and proliferation
of autologous T cells. J Immunol
1999; 163: 6251±60.
95 Yamamura M, Modlin RL, Ohmen JD,
Moy RL. Local expression of antiinflam-